Bush H - Search Results

1

Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

Golabi P, Bush H, Younossi ZM. Golabi P, et al. Among authors: bush h. Clin Liver Dis. 2017 Nov;21(4):739-753. doi: 10.1016/j.cld.2017.06.010. Epub 2017 Jul 29. Clin Liver Dis. 2017. PMID: 28987260 Review.

2

Pediatric Non-Alcoholic Fatty Liver Disease.

Bush H, Golabi P, Younossi ZM. Bush H, et al. Children (Basel). 2017 Jun 9;4(6):48. doi: 10.3390/children4060048. Children (Basel). 2017. PMID: 28598410 Free PMC article. Review.

3

Patient-Reported Outcomes and Fatigue in Patients with Chronic Hepatitis C Infection.

Golabi P, Sayiner M, Bush H, Gerber LH, Younossi ZM. Golabi P, et al. Among authors: bush h. Clin Liver Dis. 2017 Aug;21(3):565-578. doi: 10.1016/j.cld.2017.03.011. Epub 2017 Apr 26. Clin Liver Dis. 2017. PMID: 28689594 Review.

4

Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

Younossi ZM, Henry L, Bush H, Mishra A. Younossi ZM, et al. Among authors: bush h. Clin Liver Dis. 2018 Feb;22(1):1-10. doi: 10.1016/j.cld.2017.08.001. Epub 2017 Oct 14. Clin Liver Dis. 2018. PMID: 29128049 Review.

5

Nonalcoholic Fatty Liver is Contributing to the Increase in Cases of Liver Disease in US Emergency Departments.

Bush H, Golabi P, Otgonsuren M, Rafiq N, Venkatesan C, Younossi ZM. Bush H, et al. J Clin Gastroenterol. 2019 Jan;53(1):58-64. doi: 10.1097/MCG.0000000000001026. J Clin Gastroenterol. 2019. PMID: 29608451

6

Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016.

Golabi P, Bush H, Stepanova M, Locklear CT, Jacobson IM, Mishra A, Trimble G, Erario M, Venkatesan C, Younossi I, Goodman Z, Younossi ZM. Golabi P, et al. Among authors: bush h. Medicine (Baltimore). 2018 Aug;97(31):e11518. doi: 10.1097/MD.0000000000011518. Medicine (Baltimore). 2018. PMID: 30075518 Free PMC article.

7

Hospice care in Medicare patients with primary liver cancer: the impact on resource utilisation and mortality.

Fukui N, Golabi P, Otgonsuren M, de Avila L, Bush H, Younossi ZM. Fukui N, et al. Among authors: bush h. Aliment Pharmacol Ther. 2018 Mar;47(5):680-688. doi: 10.1111/apt.14484. Epub 2018 Jan 3. Aliment Pharmacol Ther. 2018. PMID: 29314093

8

Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD).

Golabi P, Stepanova M, Pham HT, Cable R, Rafiq N, Bush H, Gogoll T, Younossi ZM. Golabi P, et al. Among authors: bush h. BMJ Open Gastroenterol. 2018 Mar 20;5(1):e000198. doi: 10.1136/bmjgast-2018-000198. eCollection 2018. BMJ Open Gastroenterol. 2018. PMID: 29607054 Free PMC article.

9

Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality.

Shahab O, Biswas R, Paik J, Bush H, Golabi P, Younossi ZM. Shahab O, et al. Among authors: bush h. Hepatol Commun. 2018 Sep 24;2(10):1227-1234. doi: 10.1002/hep4.1241. eCollection 2018 Oct. Hepatol Commun. 2018. PMID: 30288477 Free PMC article.

10

Implementation of Value-based Medicine (VBM) to Patients With Chronic Hepatitis C (HCV) Infection.

Bush H, Rafiq N, Younossi ZM. Bush H, et al. J Clin Gastroenterol. 2019 Apr;53(4):262-268. doi: 10.1097/MCG.0000000000001174. J Clin Gastroenterol. 2019. PMID: 30681638

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

457 results

Search Page